Search Within

Lauren E Abrey

  1. "Kathryn Beal"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (6)
Groups
  1. Multidisciplinary Brain Metastasis Program (16)
  2. Neuroradiology Service (11)
  3. Radiology, Department of (11)
  4. Biostatistics Service (7)
  5. Epidemiology and Biostatistics (7)
  6. Tow Center for Developmental Oncology (TCDO) (7)

More Groups

People
  1. Kathryn Beal (16)
  2. Philip Gutin (16)
  3. Sasan Karimi (11)
  4. Antonio Omuro (9)
  5. Lisa De Angelis (7)
  6. Denise Correa (6)

More People

Years
  1. 2014 (1)
  2. 2013 (3)
  3. 2011 (7)
  4. 2010 (2)
  5. 2009 (3)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Journal of Clinical Oncology (4)
  3. Neuro-Oncology (3)
  4. Annals of Neurology (1)
  5. Clinical Cancer Research (1)
  6. Medical Physics (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (4)
  3. Oxford University Press (3)
  4. American Association for Cancer Research (1)
  5. American Association of Physicists in Medicine (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses
    Meeting Abstract

    Huse, J. T.; Beal, K.; Zhang, J.; Kastenhuber, E. R.; Kaley, T. J.; Abrey, L. E.; Gutin, P. H.; Brennan, C. W.; Omuro, A. M. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Diffusion and perfusion magnetic resonance imaging in newly diagnosed glioblastoma following treatment with Bevacizumab, Temozolomide and hypo-fractionated stereotactic radiotherapy (HFSRT)
    Meeting Abstract

    Daras, M.; Karimi, S.; Abrey, L.; Sanchez, J.; Beal, K.; Gutin, P.; Kaley, T.; Grommes, C.; Correa, D.; Reiner, A.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma
    Journal Article

    Shapiro, L. Q.; Beal, K.; Goenka, A.; Karimi, S.; Iwamoto, F. M.; Yamada, Y.; Zhang, Z.; Lassman, A. B.; Abrey, L. E.; Gutin, P. H.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
    Meeting Abstract

    Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy
    Meeting Abstract

    Correa, D. D.; Baser, R.; Beal, K.; Karimi, S.; DeAngelis, L.; Panageas, K.; Barradas, R.; Statucka, M.; Abrey, L.; Gutin, P.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ) and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Beal, K.; Omuro, A.; Karimi, S.; Correa, D.; Chan, T. A.; Deangelis, L. M.; Yamada, Y.; Abrey, L. E.; Gutin, P. H.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma
    Journal Article

    Ballangrud, A. M.; Lymberis, S.; Thakur, S. B.; Karimi, S.; Huang, W.; Abrey, L. E.; Beal, K.; Iwamoto, F. M.; Brennan, C.; Gutin, P. H.; more...
    Medical Physics (2011)

    Fulltext@MSK | Save